GlassScriptPhysician profile
Paul Stephen Richard
NPI 1689806465
$7,116.98
in general payments reported to CMS, 2019-2025
31 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $369 · 2021: $586 · 2022: $325 · 2023: $4,358 · 2024: $549 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,632 · Food and Beverage: $1,318 · Entertainment: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,632.26 |
| Food and Beverage | $1,317.68 |
| Entertainment | $302.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $3,838.25 | 2021-2023 | Other - Miscellaneous |
| Nuvasive, INC. | $992.36 | 2019-2021 | |
| Arthrex, INC. | $424.00 | 2024-2025 | |
| Kaneka Medical America LLC | $302.57 | 2023 | |
| Medtronic, INC. | $241.00 | 2023 | Unid_pass, Magnifuse Bone Graft |
| Integrity Implants INC. | $164.24 | 2022 | |
| Providence Medical Technology, INC. | $125.71 | 2025 | |
| Depuy Synthes Sales INC. | $116.55 | 2020-2022 | |
| Organogenesis INC. | $104.51 | 2024 | Nushield |
| Astrazeneca Pharmaceuticals LP | $80.53 | 2024 | Andexxa |
| Si-Bone, INC. | $79.60 | 2021 | |
| Kuros Biosciences USA, INC | $77.45 | 2023 | |
| Nevro Corp. | $74.89 | 2023-2024 | Senza |
| Eisai INC. | $50.60 | 2023-2024 | |
| Stryker Corporation | $44.92 | 2022-2024 | Duramatrix, Universal Neuro 3 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $39.73 | 2019 | |
| Abbvie INC. | $39.19 | 2023 | |
| Seaspine Orthopedics Corporation | $37.98 | 2022 | |
| Terumo Medical Corporation | $34.77 | 2019 | |
| Carlsmed, INC. | $26.18 | 2021 | |
| Baxter Healthcare | $25.29 | 2023 | Floseal |
| Lundbeck LLC | $23.53 | 2024 | Vyepti |
| Kerecis Limited | $23.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Radius Health, INC. | $22.18 | 2019 | |
| Abbott Laboratories | $21.24 | 2022 | |
| Integra Lifesciences Corporation | $20.15 | 2019 | |
| Vertos Medical, INC. | $19.58 | 2022 | |
| Spineology INC. | $18.45 | 2019 | |
| Acorda Therapeutics, INC | $18.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.64 | 2019 | |
| Amgen INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.